T-group (topology)
296.1.1 Sulfite reductase hemoprotein (SiRHP), domains 2 and 4
Ligands and drugs
1,058
Member domains
186
with ligand contacts (≤ 4 Å)
17.6% of members
184
with DrugDomain annotations
17.4% of members
171
with a DrugBank compound
16.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 296.1.1 belongs to X-group 296 Sulfite reductase hemoprotein (SiRHP), domains 2 and 4, which has 17 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02832 | SRM | Siroheme | 166 |
| DB12529 | NO2 | Nitrite | 12 |
| DB11588 | CMO | Carbon monoxide | 3 |
| DB03961 | CDI | 2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SRM | SIROHEME | 168 |
| SF4 | IRON/SULFUR CLUSTER | 135 |
| CL | CHLORIDE ION | 59 |
| Kmetal | POTASSIUM ION | 19 |
| SO3 | SULFITE ION | 18 |
| H2S | HYDROSULFURIC ACID | 17 |
| LImetal | LITHIUM ION | 7 |
| NO2 | NITRITE ION | 6 |
| 43Q | (3S)-1,3-dihydroxy-4-{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}-2-methylbut-2-ylium, carbokation intermediate | 3 |
| CMO | CARBON MONOXIDE | 3 |
| CYN | CYANIDE ION | 3 |
| H6P | (2E)-4-hydroxy-3-methylbut-2-en-1-yl trihydrogen diphosphate | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| NO | NITRIC OXIDE | 2 |
| 0CG | prop-2-yn-1-yl trihydrogen diphosphate | 1 |
| CAmetal | CALCIUM ION | 1 |
| CDI | 2C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE | 1 |
| F3S | FE3-S4 CLUSTER | 1 |
| FEmetal | FE (III) ION | 1 |
| HOA | HYDROXYAMINE | 1 |